Holdings
Odyssean, LLC
As of Jun 30, 2026, Odyssean, LLC reported 468 positions worth US$601M. Largest: Ultragenyx Pharmaceutical Inc., Kymera Therapeutics, Inc. and Ideaya Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 122K | US$4.08M | +54,675 | Jun 30, 2026 |
| Kymera Therapeutics, Inc. | 34,485 | US$3.95M | +19,664 | Jun 30, 2026 |
| Ideaya Biosciences, Inc. | 103K | US$3.82M | +87,308 | Jun 30, 2026 |
| Vaxcyte, Inc. | 62,638 | US$3.64M | +42,527 | Jun 30, 2026 |
| Affirm Holdings, Inc. | 43,968 | US$3.59M | +25,579 | Jun 30, 2026 |
| Celldex Therapeutics, Inc. | 95,069 | US$3.54M | new | Jun 30, 2026 |
| Loar Holdings Inc. | 43,660 | US$3.52M | +22,996 | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 29,924 | US$3.5M | +17,952 | Jun 30, 2026 |
| Doordash, Inc. | 18,915 | US$3.49M | new | Jun 30, 2026 |
| Krystal Biotech, Inc. | 9,349 | US$3.47M | +4,530 | Jun 30, 2026 |